Regencell Bioscience Holdings Ltd (RGC) › Operating IncomeRegencell Bioscience Holdings Ltd (RGC) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$391.0K2020: -$812.4K2021: -$1.38M2022: -$7.62M2023: -$6.27M2024: -$4.74M2025: -$3.77M-$3.77M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$3.77M+20.4%2024-$4.74M+24.5%2023-$6.27M+17.6%2022-$7.62M-451.5%2021-$1.38M-70.0%2020-$812.4K-107.8%2019-$391.0K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share